(Q56912280)

English

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer

scientific article published on 01 November 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Elisa Martín-Merino

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Saga Johansson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Thomas Morris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Luis A García Rodríguez

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1061-1077

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21981434%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Association between captopril, other antihypertensive drugs and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Testosterone deficiency: a risk factor for cardiovascular disease?

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Non-classical actions of testosterone: an update.

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Testosterone and cardioprotection against myocardial ischemia

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.2165%2F11594540-000000000-00000

21 January 2018

Physiologic basis for hormonal theapy in carcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The General Practice Research Database. Scientific and Ethical Advisory Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21981434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56912280&oldid=2213181818"